Y-site compatibility of co-administered continuous infusion solutions
"Y-site administration of 16 binary admixtures identified as incompatible is not recommended. The preparatory study results are suitable to complete incompatibility-reducing infusion schemes. Clinical pharmacists should implement incompatibility-reducing tools in intensive care patients" Kreysing et al (2026).